Role of Rostromedial Tegmental Nucleus in alcohol addiction

DESCRIPTION (provided by applicant): The neurobiological mechanisms underlying the addictive property of ethanol remain obscure. It is generally accepted that the addictive property of ethanol is associated with its ability to increase the activity of dopaminergic neurons in the ventral tegmental area (VTA) in the brain. These neurons are under the powerful control of synaptic inputs. Thus, the synaptic regulation of dopaminergic neurons is a key initial step in reward mechanisms leading to alcohol addiction. The majority of the afferents to dopaminergic neurons are GABAergic and usually inhibitory. Some drugs of abuse, such as opioids, stimulate VTA-dopaminergic neurons through suppression of GABAergic transmission - that is by disinhibition. Emerging evidence indicates that the rostromedial tegmental nucleus (RMTg), a newly defined structure with dense ?-opioid receptor immunoreactivity, is a major GABAergic afferent to dopaminergic neurons, and a key structure in ?-opioid receptor-dependent regulation of dopaminergic neurons. However, the functional mechanisms connecting the RMTg inputs to the dopaminergic neurons with alcohol drinking behavior remain obscure. Our long term goal is to understand the neurobiological mechanisms underlying alcohol addiction. The objective in this application is to define RMTg's role in ethanol drinking behavior by identifying its contribution to ethanol-induced activation of VTA dopaminergic neurons and determining the influence of RMTg neuronal activity on ethanol intake. Our proposed experiments will specifically test the central hypothesis that the RMTg projection to VTA dopaminergic cells plays a key role in the control of regulating ethanol drinking behavior by strongly regulating ethanol-induced enhancement of VTA-dopaminergic neuron activity. This central hypothesis will be tested in two separate but integrated Aims. Aim 1 will combine ex vivo electrophysiology, tract tracing experiments, targeted neuronal activation/inactivation, molecular genetics and optogenetic techniques to functionally dissect a neuronal circuit important for acute ethanol's action on dopaminergic neurons. Aim 2 will determine the effect of altering RMTg activity on ethanol intake. To test the hypothesis that the RMTg plays a key role in ethanol drinking, we will manipulate RMTg function by intra-RMTg infusion of relevant pharmacological agents and then study consequent changes in ethanol intake, using the intermittent 2-bottle choice paradigm. The studies are significant because they will advance our knowledge of the neural circuitries that determine excessive alcohol consumption. The proposed studies are innovative, because they will characterize a previously understudied effect of ethanol on the RMTg neurons, and its subsequent indirect effect on VTA-dopaminergic neurons, as well as the role of ?-opioid receptors in the RMTg in drinking behavior. The results of this project will provide valuable information on novel mechanisms underlying the addictive properties of alcohol and should identify novel cellular targets for the development of improved treatment of alcoholism.